Skip to main content

Advertisement

SpringerLink
Log in

Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro

  • Original Article
  • Published:
Tumor Biology

Abstract

Special AT-rich sequence-binding protein-1 (SATB1) is critical for genome organizer that reprograms chromatin organization and transcription profiles, and associated with tumor growth and metastasis in several cancer types. Many studies suggest that SATB1 overexpression is an indicator of poor prognosis in various cancers, such as breast cancer, malignant cutaneous melanoma, and liver cancer. However, their expression patterns and function values for adult T cell leukemia (ATL) are still largely unknown. The aim of this study is to examine the levels of SATB1 in ATL and to explore its function and mechanisms in Jurkat cell line. Here, we reported that SATB1 expressions were decreased in ATL cells (p < 0.001) compared with normal controls. Knockdown of SATB1 expression significantly enhanced invasion of Jurkat cell in vitro. Furthermore, knockdown of SATB1 gene enhances β-catenin nuclear accumulation and transcriptional activity and thus may increase the invasiveness of Jurkat cell through the activation of Wnt/β-catenin signaling pathway in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chiaretti S, Gianfelici V, Ceglie G, Foa R. Genomic characterization of acute leukemias. Med Princ Pract. 2014;23(6):487–506.

    Article  PubMed  Google Scholar 

  2. Soyoral Y, Aslan M, Ebinc S, Dirik Y, Demir C. Life-threatening hypophosphatemia and/or phosphate depletion in a patient with acute lymphoblastic leukemia: a rare case report. Am J Emerg Med 2014. doi: 10.S0735-6757(14)00255-1.

  3. Zeng H, Wang XB, Cui NH, Nam S, Zeng T, Long X. Associations between AT-rich interactive domain 5B gene polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(15):6211–7.

    Article  PubMed  Google Scholar 

  4. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943–55.

    Article  PubMed  Google Scholar 

  5. Sabir N, Iqbal Z, Aleem A, Awan T, Naeem T, Asad S, et al. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome. Asian Pac J Cancer Prev. 2012;13(7):3349–55.

    Article  PubMed  Google Scholar 

  6. Huang Y, Zhang L, Song NN, Hu ZL, Chen JY, Ding YQ. Distribution of Satb1 in the central nervous system of adult mice. Neurosci Res. 2011;71(1):12–21.

    Article  CAS  PubMed  Google Scholar 

  7. Richon VM. A new path to the cancer epigenome. Nat Biotechnol. 2008;26(6):655–6.

    Article  CAS  PubMed  Google Scholar 

  8. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature. 2002;419(6907):641–5.

    Article  CAS  PubMed  Google Scholar 

  9. Osborne BA. Transcriptional control of T cell development. Curr Opin Immunol. 2000;12(3):301–6.

    Article  CAS  PubMed  Google Scholar 

  10. Burute M, Gottimukkala K, Galande S. Chromatin organizer SATB1 is an important determinant of T-cell differentiation. Immunol Cell Biol. 2012;90(9):852–9.

    Article  CAS  PubMed  Google Scholar 

  11. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, et al. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell. 2009;16(4):507–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhang Y, Tian X, Ji H, Guan X, Xu W, Dong B et al. Expression of SATB1 promotes the growth and metastasis of colorectal cancer. PLoS One. 2014;9(6).

  13. Zhang S, Gao X, Ma Y, Jiang J, Dai Z, Yin X, et al. Expression and significance of SATB1 in the development of breast cancer. Genet Mol Res. 2015;14(2):3309–17.

    Article  CAS  PubMed  Google Scholar 

  14. Liu X, Zheng Y, Qiao C, Qv F, Wang J, Ding B, et al. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics. Diagn Pathol. 2015;10:50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Niu Y, Wang L, Cheng C, Du C, Lu X, Wang G, et al. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma. APMIS. 2014;123(2):93–101.

    Article  CAS  PubMed  Google Scholar 

  16. Hedner C, Gaber A, Korkocic D, Nodin B, Uhlen M, Kuteeva E, et al. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma. Virchows Arch. 2014;465(6):649–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, et al. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci. 2011;64(1):39–44.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang L, Cheng F, He R, Chen H, Liu Y, Sun J. Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma. Cancer Biother Radiopharm. 2014;29(2):77–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, et al. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int. 2012;32(7):1064–78.

    Article  CAS  PubMed  Google Scholar 

  20. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, et al. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2010;72(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  21. Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang Y, et al. AT-rich sequence binding protein 1: contribution to tumor progression and metastasis of human ovarian carcinoma. Oncol Lett. 2012;3(4):865–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Nodin B, Hedner C, Uhlen M, Jirstrom K. Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res. 2012;5(1):24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, et al. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol. 2011;6(7):1179–89.

    Article  PubMed  Google Scholar 

  24. Wang Y, Su M, Zhou LL, Tu P, Zhang X, Jiang X, et al. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Blood. 2011;117(14):3826–35.

    Article  CAS  PubMed  Google Scholar 

  25. Ahlfors H, Limaye A, Elo LL, Tuomela S, Burute M, Gottimukkala KV, et al. SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation. Blood. 2010;116(9):1443–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, Mehta S et al. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010;8(1).

  27. Niu Z, Liu H, Zhou M, Wang H, Liu Y, Li X, et al. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2015;47(3):183–91.

    Article  Google Scholar 

  28. Liu Z, He Q, Ding X, Zhao T, Zhao L, Wang A. SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells. Int J Biochem Cell Biol. 2015;60:139–46.

    Article  CAS  PubMed  Google Scholar 

  29. Choi YL, Tsukasaki K, O’Neill MC, Yamada Y, Onimaru Y, Matsumoto K, et al. A genomic analysis of adult T-cell leukemia. Oncogene. 2007;26(8):1245–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Natural Science Foundation of China (81200399), Key Clinical Disciplines of Guangdong Province (20111219), Guangdong Province Natural Science Foundation (2015A030310126), and Guangzhou Medical and Health Technology Program (20151A011068).

Author information

Author notes

    Authors and Affiliations

    1. Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China

      Xiao-Dan Luo, Li Tan, Dan Liu, Ya-Ya Wang, Run-Hui Zheng, Xiao-Hong Wu, Li-Hua Xu & Huo Tan

    2. Department of Hematology, The First People’s Hospital of Foshan, Foshan, 528000, China

      Shao-Jiang Yang

    3. Breast Cancer Center, The third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

      Jia-Ni Wang

    Authors
    1. Xiao-Dan Luo
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Shao-Jiang Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Jia-Ni Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Li Tan
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Dan Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ya-Ya Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Run-Hui Zheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Xiao-Hong Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Li-Hua Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Huo Tan
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Li-Hua Xu or Huo Tan.

    Ethics declarations

    Conflicts of interest

    None.

    Additional information

    Xiao-Dan Luo and Shao-Jiang Yang contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Luo, XD., Yang, SJ., Wang, JN. et al. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro. Tumor Biol. 37, 7413–7419 (2016). https://doi.org/10.1007/s13277-015-4638-x

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13277-015-4638-x

    Keywords

    Search

    Navigation